The emerging threat of fluroquinolone-, bedaquiline-, and linezolid-resistant Mycobacterium tuberculosis in China: Observations on surveillance data

The emerging threat of fluroquinolone-, bedaquiline-, and linezolid-resistant Mycobacterium tuberculosis in China: Observations on surveillance data

Background: Drug-resistant tuberculosis (TB), especially multidrug-resistant tuberculosis (MDR-TB), constitutes a major obstacle to fulfill end TB strategy globally. Although fluoroquinolones (FQs), linezolid (LZD) and bedaquiline (BDQ) were classified as Group A drugs for MDR-TB treatment, our know...

Full description

Bibliographic Details
Main Authors: Shanshan Li, Yaoju Tan, Yufeng Deng, Guanghong Bai, Mingxiang Huang, Yuanyuan Shang, Yufeng Wang, Zhongtan Xue, Xuxia Zhang, Wei Wang, Junhua Pan, Yu Pang
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Journal of Infection and Public Health
Subjects:
Tuberculosis
Drug susceptibility
Bedaquiline
Linezolid
Fluoquinolone
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034123004057

Internet

http://www.sciencedirect.com/science/article/pii/S1876034123004057

Similar Items